Oncolytics Biotech Inc (ONCY)
1.03
-0.01
(-0.96%)
USD |
NASDAQ |
Apr 19, 12:05
Oncolytics Biotech Total Liabilities (Quarterly): 8.486M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 8.486M |
September 30, 2023 | 12.56M |
June 30, 2023 | 7.34M |
March 31, 2023 | 7.080M |
December 31, 2022 | 7.981M |
September 30, 2022 | 7.723M |
June 30, 2022 | 7.347M |
March 31, 2022 | 7.554M |
December 31, 2021 | 7.671M |
September 30, 2021 | 7.747M |
June 30, 2021 | 7.922M |
March 31, 2021 | 7.535M |
December 31, 2020 | 7.523M |
September 30, 2020 | 7.673M |
June 30, 2020 | 7.772M |
March 31, 2020 | 7.842M |
December 31, 2019 | 15.13M |
September 30, 2019 | 9.695M |
June 30, 2019 | 8.771M |
March 31, 2019 | 8.060M |
December 31, 2018 | 6.365M |
September 30, 2018 | 7.044M |
June 30, 2018 | 7.337M |
March 31, 2018 | 7.266M |
December 31, 2017 | 7.846M |
Date | Value |
---|---|
September 30, 2017 | 2.237M |
June 30, 2017 | 2.546M |
March 31, 2017 | 2.511M |
December 31, 2016 | 3.018M |
September 30, 2016 | 2.136M |
June 30, 2016 | 2.149M |
March 31, 2016 | 1.968M |
December 31, 2015 | 1.952M |
September 30, 2015 | 2.440M |
June 30, 2015 | 2.464M |
March 31, 2015 | 3.372M |
December 31, 2014 | 2.906M |
September 30, 2014 | 2.955M |
June 30, 2014 | 3.437M |
March 31, 2014 | 4.373M |
December 31, 2013 | 5.643M |
September 30, 2013 | 4.763M |
June 30, 2013 | 5.176M |
March 31, 2013 | 5.536M |
December 31, 2012 | 7.329M |
September 30, 2012 | 6.841M |
June 30, 2012 | 5.130M |
March 31, 2012 | 6.091M |
December 31, 2011 | 6.371M |
September 30, 2011 | 3.351M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
7.080M
Minimum
Mar 2023
15.13M
Maximum
Dec 2019
8.492M
Average
7.747M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
Acasti Pharma Inc | 11.50M |
Aurinia Pharmaceuticals Inc | 170.11M |
Edesa Biotech Inc | 1.987M |
Lexaria Bioscience Corp | 0.2042M |
Xenon Pharmaceuticals Inc | 36.88M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 29.26M |
Shareholders Equity (Quarterly) | 20.78M |